Кардиоваскулярная терапия и профилактика (Jan 2022)

Coagulation status in patients with pulmonary embolism receiving long-term anticoagulant therapy

  • E. A. Shmidt,
  • S. A. Berns,
  • T. Yu. Penskaya,
  • I. I. Zhidkova,
  • O. V. Gruzdeva,
  • O. L. Barbarash

DOI
https://doi.org/10.15829/1728-8800-2021-3093
Journal volume & issue
Vol. 20, no. 8

Abstract

Read online

Aim. To study the blood coagulation status by various laboratory methods in patients after pulmonary embolism (PE) receiving long-term anticoagulant therapy.Material and methods. The blood of 23 patients with pulmonary embolism, who received long-term anticoagulant therapy, was studied. The study of coagulation profile, D-dimer, thrombodynamics, thromboelastography and thrombin generation test were carried out.Results. The thrombin generation test shows a significant increase in the time of its formation, while the maximum amount of thrombin formed is half that of the reference values. There is a slightly increased median fibrin clot growth rate in the thrombodynamics test — 30,4 gm/min with a normal coagulation rate of 20-29 gm/min. The result of thromboelastography also reflects the blood hypocoagulation, in terms of R, Angle a and CI.Conclusion. Integral methods for assessing the thrombotic readiness in combination with a routine coagulation panel demonstrate a complete picture of blood coagulation potential in patients after pulmonary embolism requiring long-term anticoagulant therapy.

Keywords